Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;19(1):1-5.
doi: 10.5114/wo.2015.50010. Epub 2015 Mar 26.

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?

Tomasz Milecki  1 , Andrzej Antczak  1 , Zbigniew Kwias  1 , Piotr Milecki  2
Affiliations
Review

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?

Tomasz Milecki et al. Contemp Oncol (Pozn). 2015.

Abstract

In recent years, significant development in the treatment of prostate cancer has taken place. One of the most documented methods of treatment in patients characterised by a high risk of progression is a combination of radiotherapy (RT) with long-term hormone therapy (HT). In this group of patients, neither RT alone nor HT alone allows satisfactory outcomes to be achieved, and therefore as monotherapy they are not recommended as optimal methods of treatment. In this review, we summarise arguments for combining radiotherapy with hormonal therapy in high-risk prostate cancer, with an emphasis on the results of phase III trials.

Keywords: combination therapy; hormone therapy; prostate cancer; radiotherapy.

PubMed Disclaimer

References

    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA CancerJ Clin. 2014;64:9–29. - PubMed
    1. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA. 2005;294:238–44. - PubMed
    1. Milecki P, Kwias Z. Hormonal therapy combined with radiotherapy in locally advanced prostate cancer. Rep Pract Oncol Radiother. 2002;7:157–63.
    1. Shelley MD, Kumar S, Coles B, Wilt T, Staffurth J, Mason MD. Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials. Cancer TreatRev. 2009;35:540–6. - PubMed
    1. Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst. 2003;95:981–9. - PMC - PubMed

LinkOut - more resources